Market Cap
Abbott Laboratories
$178.02 Billion
USD as of July 1, 2024
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Abbott Laboratories is a multinational health care and medical devices company. Founded in 1888, Abbot manufactures medical devices including cardiovascular and neuromodulation devices, diagnostics products, branded generic medicines, and nutritional products for children and adults including Pedialyte, Similac, Ensure, Glucerna, ZonePerfect, FreeStyle Libre, i-STAT, and MitraClip.
Abbott Laboratories has the following listings and related stock indices.
Stock: NYSE: ABT
Stock: BCBA: ABT
Stock: BMV: ABT
Stock: Bovespa: ABTT34
Stock: BVS: ABTCL
Stock: FSX: ABL
Stock: XETR: ABL
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.